Kistler-Tiffany Companies’s Biogen BIIB Stock Holding History

Kistler-Tiffany Companies’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.97K	Hold	35	–	–	﹤0.01%	704
2023 Q1	$9.73K	Hold	35	–	–	﹤0.01%	634
2022 Q4	$9.69K	Hold	35	–	–	﹤0.01%	631
2022 Q3	$9K	Hold	35	–	–	﹤0.01%	606
2022 Q2	$7K	Hold	35	–	–	﹤0.01%	620
2022 Q1	$7K	Hold	35	–	–	﹤0.01%	639
2021 Q4	$8K	Sell	35 -84	-71%	-$21.6K	﹤0.01%	613
2021 Q3	$34K	Hold	119	–	–	0.01%	417
2021 Q2	$41K	Hold	119	–	–	0.01%	387
2021 Q1	$33K	Hold	119	–	–	0.01%	383
2020 Q4	$29K	Hold	119	–	–	0.01%	372
2020 Q3	$34K	Hold	119	–	–	0.01%	317
2020 Q2	$32K	Hold	119	–	–	0.01%	302
2020 Q1	$35K	Hold	119	–	–	0.01%	292
2019 Q4	$35K	Buy	119 +35	+42%	+$9.71K	0.01%	299
2019 Q3	$20K	Buy	+84	New	+$19.6K	0.01%	362

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kistler-Tiffany Companies's BIIB Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Biogen (BIIB) position steady in Q2 2023 at 35 shares worth $9.97K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Kistler-Tiffany Companies first reported a position in BIIB in Q3 2019 and has held it in 16 quarters since. The position peaked at $41K in Q2 2021. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Kistler-Tiffany Companies held 35 shares of Biogen worth $9.97K as of Q2 2023.
Kistler-Tiffany Companies left its Biogen share count unchanged in Q2 2023.
Biogen made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #704 holding.
Kistler-Tiffany Companies first reported a position in Biogen in Q3 2019 and has held it in 16 quarters since.
Kistler-Tiffany Companies's Biogen position peaked at $41K in Q2 2021.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.